SIMPLEX GTP LIMITED
Company number 03484533 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: SIMPLEX GTP LIMITED
1. Financial Health Score: B (Stable but Dormant) This company receives a grade of "B" not because it is thriving with robust operational activity, but because its structural and regulatory vitals are perfectly healthy. The company is in a state of corporate hibernation—alive, but not actively trading. There are no symptoms of financial distress, insolvency, or administrative neglect. However, because the business is currently generating no operational pulse, it cannot receive an "A" grade for overall financial wellness.
2. Key Vital Signs * Pulse (Trading Activity): Flatline. The company is officially classified as "Dormant" by Companies House. This indicates that the company has no significant accounting transactions during the financial year. It is clinically alive but not performing any active business functions. * Blood Pressure (Capital Base): Stable. The company has a stated share capital of £987,010.58. This is a substantial capital reserve, acting like a healthy blood pressure reading, suggesting the company was well-capitalized either at inception or during its prior active life. * Nervous System (Corporate Governance): Responsive. Filings are up to date, with accounts not due until March 2028 and confirmation statements current. There are no overdue filings, meaning the company is not suffering from administrative neglect. * Immune System (Director Health): Clear. There are three active directors, and a review of the public records shows no disqualification orders or histories of misconduct. The "immune system" is strong with no signs of infection from poor leadership. * Genetics (Ownership Structure): Wholly Owned Subsidiary. Bottomline Technologies Incorporated (a major US-based financial technology company) owns more than 75% of the shares, holds over 75% of the voting rights, and retains the right to appoint and remove directors. This company is a wholly controlled subsidiary.
3. Diagnosis Based on the financial data and corporate history, the diagnosis is Benign Corporate Hibernation.
SIMPLEX GTP LIMITED is not suffering from a terminal illness; rather, it is a patient resting in a long-term care facility funded by a wealthy parent. Incorporated in late 1997, the company was once active under previous names (Simplex UK Limited and Simplex Consulting Limited) operating in the IT services sector (SIC 62090). At some point after 2012, the business operations were either absorbed by its parent company or ceased, leaving the UK shell dormant.
The presence of nearly £1 million in share capital alongside a "Dormant" accounts status suggests the parent company uses this entity as a balance sheet vehicle or a strategic shell, keeping it on life support for legal, structural, or intellectual property reasons rather than for day-to-day trading. There are absolutely no symptoms of distress, insolvency, or administration.
4. Recommendations * Routine Maintenance: The primary prescription is to continue routine administrative care. Ensure confirmation statements and dormant accounts are filed on time to prevent regulatory penalties or fines, which act like preventable infections. * Strategic Review: For the parent company (Bottomline Technologies), it is worth conducting a periodic review to ask: "Do we still need this patient on life support?" If the entity no longer serves a strategic legal or structural purpose, the most cost-effective measure would be to voluntarily strike it off the register (pull the plug), thereby saving on ongoing administrative and compliance costs. * Stakeholder Awareness: Any stakeholders, vendors, or potential partners examining this entity must understand that they are looking at a dormant shell. Any business operations, revenues, and financial wellness are to be found within the parent company, Bottomline Technologies, not within this UK subsidiary.